Clinical Trial Update: Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability and pharmacokinetics of multiple ascending doses of VV119 in schizophrenia; study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• VV119 (VV119)

Snippet

Sponsor: Vigonvita Life Sciences | Conditions: Schizophrenia | Phase 1 | Status: RECRUITING